Targeting sudden death in heart failure with preserved ejection fraction: promise or pipedream?

Ravi B. Patel, Muthiah Vaduganathan*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)875-877
Number of pages3
JournalExpert review of cardiovascular therapy
Volume16
Issue number12
DOIs
StatePublished - Dec 2 2018

Funding

RB Patel is supported by the NHLBI T32 postdoctoral training grant (T32HL069771). M Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award KL2 TR002542), and serves on advisory boards for Bayer AG and Baxter Healthcare. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

Keywords

  • Heart failure with preserved ejection fraction
  • risk prediction
  • sudden cardiac death

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this